Infant Health and Later-Life Labor Market Outcomes

References

1. ↵
   1. Adhvaryu Achyuta,
   2. Bednar Steven,
   3. Nyshadham Anant,
   4. Molina Teresa,
   5. Nguyen Quynh

   . 2018. “When It Rains It Pours: The Long-Run Economic Impacts of Salt Iodization in the United States.” NBER Working Paper 24847. Cambridge, MA: NBER.
2. ↵
   1. Almond Douglas,
   2. Currie Janet

   . 2011. “Human Capital Development before Age Five.” In Handbook of Labor Economics, Volume 4B, Developments in Research Methods and Their Application, ed. Card David, Ashenfelter Orley, 1315–468. New York: Elsevier.
3. ↵
   1. Almond Douglas,
   2. Currie Janet,
   3. Duque Valentina

   . 2018. “Childhood Circumstances and Adult Outcomes: Act II.” Journal of Economic Literature 56(4):1360–446.

   OpenUrl
4. ↵
   1. Andersson Oscar

   . 1939. (“Practice and Modern Pneumonia Treatment.”) [In Swedish.] Läkartidningen 23:1190–5.

   OpenUrl
5. ↵
   1. Barker David

   . 1994. Mothers, Babies, and Disease in Later Life. London: British Medical Journal Publishing Group.
6. ↵
   1. Barreca Alan I.

   2010. “The Long-Term Economic Impact of In Utero and Postnatal Exposure to Malaria.” The Journal of Human Resources 45(4):865–92.

   OpenUrlAbstract/FREE Full Text
7. ↵
   1. Bengtsson Tommy,
   2. Dribe Martin

   . 2014. “The Historical Fertility Transition at the Micro Level: Southern Sweden 1815–1939.” Demographic Research S14(17):493–534.

   OpenUrl
8. ↵
   1. Bentley Ronald

   . 2009. “Different Roads to Discovery; Prontosil (Hence Sulfa Drugs) and Penicillin (Hence Beta-Lactams).” Journal of Industrial Microbiology & Biotechnology 36(6):775–86.

   OpenUrl
9. ↵
   1. Beyerlein Andreas,
   2. Donnachie Ewan,
   3. Jergens Sibille,
   4. Ziegler Anette-Gabriele

   . 2016. “Infections in Early Life and Development of Type 1 Diabetes.” JAMA 315(17):1899–901.

   OpenUrlPubMed
10. ↵
    1. Bhalotra Sonia,
    2. Karlsson Martin,
    3. Nilsson Therese,
    4. Schwarz Nina

    . 2016. “Infant Health, Cognitive Performance and Earnings: Evidence from Inception of the Welfare State in Sweden.” IZA Working Paper 10339. Bonn, Germany: IZA.
11. ↵
    1. Bhalotra Sonia,
    2. Venkataramani Atheendar S.

    2013. “Shadows of the Captain of the Men of Death: Early Life Health Interventions, Human Capital Investments, and Institutions.” IZA Working Paper 7833. Bonn, Germany: IZA.
12. ↵
    1. Bleakley Hoyt

    . 2007. “Disease and Development: Evidence from Hookworm Eradication in the American South.” Quarterly Journal of Economics 122(1):73–117.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Bleakley Hoyt

    . 2010a. “Health, Human Capital, and Development.” Annual Review of Economics 2:283–310.

    OpenUrlCrossRefPubMed
14. ↵
    1. Bleakley Hoyt

    . 2010b. “Malaria Eradication in the Americas: A Retrospective Analysis of Childhood Exposure.” American Economic Journal: Applied Economics 2(2):1–45.

    OpenUrl
15. ↵
    1. Case Anne,
    2. Paxson Christina

    . 2009. “Early Life Health and Cognitive Function in Old Age.” American Economic Review 99(2):104–9.

    OpenUrlCrossRef
16. ↵
    1. Colebatch Alexandra N.,
    2. Edwards Chris J.

    2011. “The Influence of Early Life Factors on the Risk of Developing Rheumatoid Arthritis.” Clinical and Experimental Immunology 163(1): 11–16.

    OpenUrlCrossRefPubMed
17. ↵
    1. Cronberg Stig

    . 1997. (“Infections: Illness, Environment, Treatment.”) [In Swedish.] Stockholm: Liber.
18. ↵
    1. Cunha Flavio,
    2. Heckman James

    . 2007. “The Technology of Skill Formation.” The American Economic Review 97(2):31–47.

    OpenUrlCrossRefWeb of Science
19. ↵
    1. Cutler David,
    2. Fung Winnie,
    3. Kremer Michael,
    4. Singhal Monica,
    5. Vogl Tom

    . 2010. “Early-Life Malaria Exposure and Adult Outcomes: Evidence from Malaria Eradication in India.” American Economic Journal: Applied Economics 2(2):72–94.

    OpenUrlCrossRefWeb of Science
20. ↵
    1. Finch Caleb E.

    2007. The Biology of Human Longevity. Oxford: Elsevier.
21. ↵
    1. Finch Caleb E.,
    2. Crimmins Eileen

    . 2004. “Inflammatory Exposure and Historical Changes in Human Life-Spans.” Science 305(5691):1736–9.

    OpenUrlAbstract/FREE Full Text
22. ↵
    1. Fischer Martin,
    2. Karlsson Martin,
    3. Nilsson Therese

    . 2013. “Effects of Compulsory Schooling on Mortality: Evidence from Sweden.” International Journal of Environmental Research and Public Health 10(8):3596–618.

    OpenUrl
23. ↵
    1. Galobardes Bruna,
    2. McCarron Peter,
    3. Jeffreys Mona,
    4. Davey-Smith George

    . 2008. “Association between Early Life History of Respiratory Disease and Morbidity and Mortality in Adulthood.” Thorax 63(5):423–29.

    OpenUrlAbstract/FREE Full Text
24. ↵
    1. Glied Sherry,
    2. Neidell Matthew

    . 2010. “The Economic Value of Teeth.” The Journal of Human Resources 45(2):468–96.

    OpenUrlAbstract/FREE Full Text
25. ↵
    1. Gnosspelius A.

    1939. (“Pneumonia Treatment in Children with ‘693.’”) [In Swedish.] Läkartidningen 21:1028–34.

    OpenUrl
26. ↵
    1. Heckman James J.

    1979. “Sample Selection Bias as a Specification Error.” Econometrica 47(1):153–61.

    OpenUrlCrossRefWeb of Science
27. ↵
    1. Heckman James J.

    2007. “The Economics, Technology, and Neuroscience of Human Capability Formation.” Proceedings of the National Academy of Sciences of the United States of America 104(33):13250–55.

    OpenUrlAbstract/FREE Full Text
28. ↵
    1. Hemminki Elina,
    2. Paakulainen Anneli

    . 1976. “The Effect of Antibiotics on Mortality from Infectious Diseases in Sweden and Finland.” American Journal of Public Health 66(12): 1180–84.

    OpenUrlCrossRefPubMedWeb of Science
29. 1. Hjort Jonas,
    2. Sølvsten Mikkel,
    3. Wüst Miriam

    . 2017. “Universal Investment in Infants and Long-Run Health: Evidence from Denmark’s 1937 Home Visiting Program.” American Economic Journal: Applied Economics 9(4):78–104.

    OpenUrl
30. ↵
    1. Holmlund Helena

    . 2008. “A Researcher’s Guide to the Swedish Compulsory School Reform.” CEE DP Working Paper 87. London, UK: Centre for the Economics of Education, London School of Economics and Political Science.
31. ↵
    1. Ingvar Sven

    . 1939. (“On the Treatment of Croupous Pneumonia.”) [In Swedish.] Läkartidningen 1:11–57.

    OpenUrl
32. ↵
    1. Kelly Elaine

    . 2011. “The Scourge of Asian Flu: In Utero Exposure to Pandemic Influenza and the Development of a Cohort of British Children.” Journal of Human Resources 46(4):669–94.

    OpenUrlAbstract/FREE Full Text
33. ↵
    1. Kesternich Iris,
    2. Siflinger Bettina,
    3. Winter Joachim K.,
    4. Smith James P.

    2014. “The Effects of World War II on Economic and Health Outcomes across Europe.” Review of Economics and Statistics 96(1):103–18.

    OpenUrlCrossRefPubMed
34. ↵
    1. Kuh Diana,
    2. Ben-Shlomo Yoav

    . 2007. A Life Course Approach to Chronic Disease Epidemiology. 2nd edition. Oxford, UK: Oxford University Press.
35. ↵
    1. Landrigan Philip J.,
    2. Sonawane Babasaheb,
    3. Butler Robert N.,
    4. Trasande Leonardo,
    5. Callan Richard,
    6. Droller Daniel

    . 2005. “Early Environmental Origins of Neurodegenerative Disease in Later Life.” Environmental Health Perspectives 113(9):1230–33.

    OpenUrlCrossRefPubMedWeb of Science
36. ↵
    1. Lazuka Volha

    . 2018. “The Long-Term Health Benefits of Receiving Treatment from Qualified Midwives at Birth.” Journal of Development Economics 133(July):415–33.

    OpenUrl
37. ↵
    1. Lindert Peter H.

    2004. Growing Public: Social Spending and Economic Growth since the Eighteenth Century. Cambridge, UK: Cambridge University Press.
38. ↵
    1. Ljungberg Jonas,
    2. Nilsson Anders

    . 2009. “Human Capital and Economic Growth: Sweden 1870–2000.” Cliometrica 3(1):71–95.

    OpenUrl
39. ↵
    1. Lucas Adrienne M.

    2010. “Malaria Eradication and Educational Attainment: Evidence from Paraguay and Sri Lanka.” American Economic Journal: Applied Economics 2(2):46–71.

    OpenUrlPubMed
40. ↵
    1. Malmros Haqvin,
    2. Wilander Olof

    . 1941. (“Should Sulfapyridine Be Used against Influenza?”) [In Swedish.] Läkartidningen 4:185–89.

    OpenUrl
41. ↵
    1. Murphy Kevin M.,
    2. Topel Robert H.

    2006. “The Value of Health and Longevity.” Journal of Political Economy 114(5):871–904.

    OpenUrlCrossRefWeb of Science
42. ↵
    1. Rahm Nils

    . 1939. (“Pneumonia Treatment.”) [In Swedish.] Läkartidningen 28:2044–60.

    OpenUrl
43. 1. Riksarkivet

    . 1920–1967. (Records of the Pharmaceutical Agency.) [In Swedish.]
44. 1. Riksarkivet

    . 1932–1936. (Historical GIS Maps in Sweden, 1569–1998.) [In Swedish.]
45. ↵
    1. Riksarkivet

    . 1989. (Swedish Parishes throughout the Centuries.) [In Swedish.]
46. ↵
    1. Rudan Igor,
    2. O’Brien Katherine L.,
    3. Nair Harish,
    4. Liu Li,
    5. Theodoratou Evropi,
    6. Qazi Shamim,
    7. Lukšič Ivana

    . 2013. “Epidemiology and Etiology of Childhood Pneumonia in 2010: Estimates of Incidence, Severe Morbidity, Mortality, Underlying Risk Factors and Causative Pathogens for 192 Countries.” Journal of Global Health 3(1):46–59.

    OpenUrl
47. ↵
    1. Schön Lennart

    . 2004. “Total Factor Productivity in Swedish Manufacturing in the Period 1870–2000.” In Exploring Economic Growth: Essays in Measurement and Analysis, ed. Heikkinen Sakari, van Zanden Jan Luiten, 273–97. Amsterdam: Aksant.
48. 1. Skånes Näringslivsarkiv

    . 1936–1945. (Leo AB and Ferrosan AB. Pharmaceutical Production.) [In Swedish.]
49. 1. Socialstyrelsen

    . 1952–2012. (Wage Statistics Yeabook for Sweden.) [In Swedish.] Stockholm: Isaac Marcus Bocktryckeri-Aktiebolag.
50. ↵
    1. SOU

    . 1948. (About Open Medical Care in the Country.) 14. [In Swedish.] Stockholm: P.A. Norstedt & Söner.
51. ↵
    1. SOU

    . 1959. (Organization of Pharmaceutical Supply.) 5. [In Swedish.] Stockholm: P.A. Norstedt & Söner.
52. 1. Statistiska Centralbyrån

    . 1920a–1950. (Causes of Death.) [In Swedish.] Stockholm: P.A. Norstedt & Söner.
53. 1. Statistiska Centralbyrån

    . 1920b–1950. (Yearbook on Health and Health Care.) [In Swedish.] Stockholm: P.A. Norstedt & Söner.
54. ↵
    1. Stocks Janet,
    2. Sonnappa Samatha

    . 2013. “Early Life Influences on the Development of Chronic Obstructive Pulmonary Disease.” Therapeutic Advances in Respiratory Disease 7(3):161–73.

    OpenUrlCrossRefPubMed
55. ↵
    1. Ström Justus

    . 1946. (“The Social Support of Future Mothers and Infants in Sweden.”) [In Swedish.] Social-Medicinsk Tidskrift 19:22–43.

    OpenUrl
56. ↵
    1. The Nobel Foundation

    . 1965. Nobel Lectures, Physiology or Medicine 1922–1941. Amsterdam: Elsevier.
57. ↵
    1. Vallgårda Signild

    . 1996. “Hospitalization of Deliveries: The Change of Place of Birth in Denmark and Sweden from the Late Nineteenth Century to 1970.” Medicinal History 40(2): 173–96.

    OpenUrl
58. ↵
    1. Venkataramani Atheendar S.

    2012. “Early Life Exposure to Malaria and Cognition in Adulthood: Evidence from Mexico.” Journal of Health Economics 31(5):767–80.

    OpenUrlPubMed
59. 1. Waldenström Daniel

    . 2014. “Swedish Stock and Bond Returns, 1856–2012.” In Historical Monetary and Financial Statistics for Sweden, Volume II, ed. Edvinsson Rodney, Waldenström Daniel, 223–92. Stockholm: Sveriges Riksbank and Ekerlids.

    OpenUrl
60. ↵
    1. Weil David N.

    2013. “Health and Economic Growth.” In Handbook of Economic Growth, ed. Aghion Philippe, Durlauf Steven N., 623–82. San Diego, CA: North Holland, Elsevier.
61. ↵
    1. WHO

    . 2013. Ending Preventable Child Deaths from Pneumonia and Diarrhoea by 2025. The Integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD). Geneva: WHO.
62. ↵
    1. Willerson James T.,
    2. Ridker Paul M.

    2004. “Inflammation as a Cardiovascular Risk Factor.” Circulation 109(21):II-2–II-10.

    OpenUrlAbstract/FREE Full Text
63. ↵
    1. Yayachandran Seema,
    2. Lleras-Muney Adriana,
    3. Smith Kimberly V.

    2010. “Modern Medicine and the Twentieth Century Decline in Mortality: Evidence on the Impact of Sulfa Drugs.” American Economic Journal: Applied Economics 2(2):118–46.

    OpenUrlCrossRefWeb of Science
64. ↵
    1. Zajacova Anna,
    2. Burgard Sarah A.

    2013. “Healthier, Wealthier, and Wiser: A Demonstration of Compositional Changes in Aging Cohorts due to Selective Mortality.” Population Research and Policy Review 32(3):1–14.

    OpenUrl